Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

AHA 2026 6 - 9 November 2026

Ziltivekimab in acute myocardial infarction: rationale, design and baseline clinical characteristics of the ARTEMIS study
    

Authors :

Jennifer Rymer1*; Roxana Mehran2*; Kevin R Bainey3; Deepak L Bhatt2; Davide Capodanno4; Anders Hvelplund5; Henrik Jarlov5; Maria D Radu Juul Jensen5; J Wouter Jukema6; Vijay Kunadian7; Adam J Nelson8; Duk-Woo Park9; Paul M Ridker10; Clara Saldarriaga11; Binita Shah12; P Gabriel Steg13; Adrian F Hernandez1Co-lead authors*

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Keywords
Cardiovascular Disease
Congress poster
Anti-IL antibody
Ziltivekimab
PHASE 3 (RCT)